Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2012
05/30/2012CN101759783B Polypeptide for localizing proteins on cell membranes and application thereof
05/30/2012CN101759782B Polypeptide for localizing proteins on cell membranes and/or cell walls and application thereof
05/30/2012CN101757610B Application of snake venom cytotoxin -CTX1 in the preparation of drugs with analgesic function
05/30/2012CN101724634B New purpose of zinc finger protein genes
05/30/2012CN101724013B Method for separating and purifying immunoglobulin A, immunoglobulin G and lactoferrin from bovine colostrum in industrializing way
05/30/2012CN101724012B Deep processing method for cultivated gardon asparagus in gracilaria
05/30/2012CN101717759B Method for improving biological macromolecule crystallization condition screening success rate by using drying agent
05/30/2012CN101712941B Paenibacillus polymyxa and application thereof
05/30/2012CN101704882B Plant yellow dwarf resistance-associated protein, coding gene and application thereof
05/30/2012CN101643505B Nitrofuran compound and preparation method and application thereof
05/30/2012CN101547935B Interferon alpha mutant and its polyethylene glycol derivative
05/30/2012CN101519663B Recombinant CREG protein and application thereof
05/30/2012CN101501066B Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use
05/30/2012CN101443022B Use of a growth-stimulating protein
05/30/2012CN101423549B Ibtip1 gene from sweet potato root and promoter thereof
05/30/2012CN101356191B Neuropeptides for the culture of aquatic organisms
05/30/2012CN101333535B Plant with improved organogenesis and method of constructing the same
05/30/2012CN101302528B Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences coding these polypeptides and their uses
05/30/2012CN101255430B Gene encoding glycogen synthesis initiator and use thereof
05/30/2012CN101248085B Polypeptides having antimicrobial activity and polynucleotides encoding same
05/30/2012CN101193915B Monoclonal antibodies and methods for their use in the detection of cervical disease
05/30/2012CN101146818B Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
05/30/2012CN101002549B Transgenic non-human animals capable of producing heterologous antibodies
05/29/2012US8188339 Sugar and lipid metabolism regulators in plants IV
05/29/2012US8188248 Nucleic acids encoding interleukin-12P40 variants with improved stability
05/29/2012US8188246 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use
05/29/2012US8188244 Carcinoembryonic antigen fusions and uses thereof
05/29/2012US8188241 Immobilized proteins and methods and uses thereof
05/29/2012US8188236 Eta-1 gene and methods for use
05/29/2012US8188230 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
05/29/2012US8188226 High activity growth factor mutants
05/29/2012US8188225 Inorganic phosphate assays
05/29/2012US8188224 Variant forms of urate oxidase and use thereof
05/29/2012US8188219 Cyclic peptide for use in diagnosis, prevention and treatment of bone disorders
05/29/2012US8188218 Bi-functional peptides for multiple sclerosis treatment and diagnosis
05/29/2012US8188215 Metal-binding compounds and uses therefor
05/29/2012US8188213 Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI)
05/29/2012US8188056 Utilizing nucleic acid expression constructs that are delivered into a subject and express stable therapeutic proteins in vivo
05/29/2012US8188051 Metadherin polypeptides, encoding nucleic acids and methods of use
05/29/2012US8188046 Amyloid beta peptides and methods of use
05/29/2012US8188045 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
05/29/2012US8188044 Anti-tumor drug, medicament, composition, and use thereof
05/29/2012US8188040 FGF21 mutants and uses thereof
05/29/2012US8188039 VEGF-D mutants and their use
05/29/2012US8188036 Genes encoding novel proteins with pesticidal activity against coleopterans
05/29/2012US8188035 Method for using nano carbon to refine collagen into nanoparticulate collagen
05/29/2012US8188032 G-CSF transferrin fusion proteins
05/29/2012US8187871 Co-crystallization of ERR-α with a ligand that forms a reversible covalent bond
05/29/2012US8187851 Method of forming a molded protein matrix for a sensor
05/29/2012US8187837 Optimized purification process of recombinant growth factor protein
05/29/2012US8187834 For inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell comprising a Targeting Moiety, a non-cytotoxic protease and a Translocation Domain; pain
05/29/2012US8187831 Chimeric proteins, nucleic acids encoding chimeric proteins, methods and kits for assaying for sodium ions and for lithium ions in a sample, using inter alia, a 3'(2'),5'-bisphosphate nucleotidase
05/29/2012US8187822 Methods to identify modulators
05/29/2012US8187819 Methods of identifying compounds that bind TANGO240
05/29/2012US8187612 Neuromuscular disorders
05/29/2012US8187607 Hapten-carrier conjugates and uses thereof
05/29/2012US8187605 Means for the inhibition of anti-β1-adrenergic receptor antibodies
05/29/2012US8187598 Methods of treating cancer by administering antibodies to CD200
05/29/2012US8187587 Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
05/29/2012US8187586 Methods of inducing apoptosis in hyperproliferative cells
05/29/2012US8187584 Human tumor necrosis factor-α mutants
05/29/2012CA2617803C Nucleotide sequences encoding insecticidal proteins
05/29/2012CA2616914C Egfr-binding antibody
05/29/2012CA2557910C Methods of reducing aggregation of il-1ra
05/29/2012CA2549914C A novel protein capable of inhibiting anthrax toxin activity
05/29/2012CA2518927C Arrays and methods
05/29/2012CA2516022C Model for studying the role of genes in tumor resistance to chemotherapy
05/29/2012CA2514584C Peptide inhibitors of toxins derived from ll-37
05/29/2012CA2478616C Use of adenoviruses mutated in the va genes for cancer treatment
05/29/2012CA2455403C Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/29/2012CA2441597C Elongated and multiple spacers in activatible prodrugs
05/29/2012CA2440767C Novel neurotrophic factors
05/29/2012CA2431321C Monoclonal antibodies to human immunodeficiency virus and uses thereof
05/29/2012CA2406191C Cestrum yellow leaf curling virus promoters
05/29/2012CA2403327C Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
05/29/2012CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2379388C Immunoglobulin fusion proteins
05/29/2012CA2377957C Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
05/29/2012CA2365099C Transgenic plants that are resistant to a broad spectrum of pathogens
05/29/2012CA2361292C A novel chimeric protein for prevention and treatment of hiv infection
05/29/2012CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/29/2012CA2341340C Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
05/29/2012CA2338005C Peptide antagonists of zonulin and methods for use of the same
05/29/2012CA2329148C Specific binding proteins for treating canine allergy
05/29/2012CA2251604C Human hematopoietic stem and progenitor cell antigen and methods for its use
05/24/2012WO2012068380A2 Methods and compositions for modulating pd1
05/24/2012WO2012068236A2 Novel fungal oxidoreductases
05/24/2012WO2012068167A1 Use of manganese peroxidase for enzymatic hydrolysis of lignocellulosic material
05/24/2012WO2012067466A2 Yarrowia lipolytica-derived peptide-n-glycosidase, and use thereof
05/24/2012WO2012067402A2 Red fluorescent protein fragment having a self-assembly activity, method for preparing same, and method for analyzing protein-protein interactions using same
05/24/2012WO2012066481A1 New ethiological agent
05/24/2012WO2012066420A1 Lipidated polyepitope vaccines
05/24/2012WO2012066376A1 Inhibitors of apoptosis and uses thereof
05/24/2012WO2012066331A1 Cross protective epitopes of aspergillus fumigatus and candida albicans
05/24/2012WO2012066140A1 Method for monitoring physical training in healthy and diseased individuals
05/24/2012WO2012066103A2 Inhibitors of apoptosis and uses thereof
05/24/2012WO2012066075A1 Methods of treating fgf21-associated disorders
05/24/2012WO2012066036A1 A PROCESS FOR REDUCTION AND/OR REMOVAL OF FXI AND FXIa FROM SOLUTIONS CONTAINING SAID COAGULATION FACTORS
05/24/2012WO2012065978A1 Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 2916